The Pharma Trends & Stocks That Really Matter | CNBC-TV18

The year 2018 has been a mixed year for Indian pharma stocks. Price pressure may have eased in the US, but other challenges, especially the Chinese API supply, have emerged. American regulator USFDA is still hot on the heels of many companies.